Sonidegib

From WikiMD.org
Jump to navigation Jump to search

Sonidegib

Sonidegib (pronounced soh-ni-deh-gib) is a medication used in the treatment of basal cell carcinoma, a type of skin cancer. It is classified as a hedgehog pathway inhibitor, which works by blocking signals that contribute to the growth of cancer cells.

Etymology

The name "Sonidegib" is derived from its chemical structure. The "soni-" prefix is an arbitrary designation, while "-degib" is a suffix used for hedgehog pathway inhibitors.

Usage

Sonidegib is used to treat adults with a type of skin cancer called basal cell carcinoma that has spread to other parts of the body (metastatic) or cannot be treated with surgery or radiation (locally advanced). It is taken orally, usually once a day.

Side Effects

Common side effects of Sonidegib include muscle spasms, hair loss, taste disturbance, fatigue, nausea, diarrhea, weight loss, and decreased appetite.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski